Neurogene Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	144	340	249	-	-
Market Cap Growth	36.64%	36.64%	-	-	-
Enterprise Value	-147	214	452	-	-
Last Close Price	11.71	22.86	19.38	-	-
PE Ratio	-	-	18.20	-	-
PS Ratio	222.39	367.11	-	-	-
PB Ratio	0.56	1.09	1.34	-	-
P/TBV Ratio	1.09	1.09	1.34	-	-
EV/Sales Ratio	231.03	231.03	-	-	-
Debt / Equity Ratio	0.04	0.04	0.08	0.05	0.06
Asset Turnover	0.00	0.00	-	-	-
Quick Ratio	20.65	20.65	8.61	12.48	6.57
Current Ratio	20.84	20.84	8.72	12.74	6.81
Return on Equity (ROE)	-30.28%	-30.28%	-25.52%	-59.77%	-
Return on Assets (ROA)	-18.50%	-18.50%	-20.94%	-33.52%	-
Return on Capital (ROIC)	-19.71%	-19.71%	-22.83%	-36.31%	-
Earnings Yield	-49.10%	-22.13%	-14.61%	-	-
FCF Yield	-46.67%	-21.03%	-20.82%	-	-
Buyback Yield / Dilution	-277.22%	-277.22%	-1080.37%	90.26%	-

Updated Mar 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q